Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
CEO Erik Kinnman presents Sprint Bioscience - Erik Kinnman, CEO, Sprint Bioscience
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
CEO Erik Kinnman presents Sprint Bioscience
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Air New Zealand CEO Greg Foran on Rising Airfare Prices and Inflation | Greg Foran, CEO, Air New Zealand Ltd .
00:10:00
Investor in the trenches supporting you to close enterprise|Jessica Lin,Co-Founder and General Partner,Work-Bench
00:10:00
Ryan Chun-Jui Cheng, an MBA in International Management student, interviews Tatiana Rizzante, CEO of Reply, during the 2021 ESCP event.
00:10:00
Fueling the Next Generation of Innovators|Andy Schwab,Managing Partner,5AM Ventures
00:10:00
Attracting and Retaining Talent Through Employee Benefits
00:10:00
CTT systems at Dubai Airshow 2023 | Henrik Höjer, CEO, CTT Systems ABCTT:STO
00:10:00
Employees on Comparably rated Rogers Corporation's company culture, providing their perspectives on the workplace environment.
00:10:00
Innovating Security Solutions: Insights from Allegion Ventures | Rob Martens, Wade Sheek, and Doshia Stewart - Allegion Ventures Leadership Team
00:10:00
ERD Resources Set to Ramp Up Gold Production in 2025, Eyes Future Copper-Molybdenum Projects
00:10:00
Crypto currencies is Beyond Innovation|Michael Wu,Founder and CEO,Amber Group
00:10:00
Nissan Joseph Discusses Earnings Highlights and Growth Strategy for FY24 at Metro Brands | Nissan Joseph, CEO, Metro Brands Ltd.
00:10:00
Navigating the Polish Wine Market: Insights from Ambra SA President Robert Ogór | Robert Ogór, President , AMBRA SA.